Quantitative proteomic analysis of GnRH agonist treated GBM cell line LN229 revealed regulatory proteins inhibiting cancer cell proliferation

Plasma-derived candidate biomarkers for detection of gallbladder carcinoma

(2021) Ratna Priya et al.   Scientific Reports

Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development

(2020) Arthur T. Kopylov et al.   MOLECULES

Immunoproteomics approach revealed elevated autoantibody levels against ANXA1 in early stage gallbladder carcinoma

(2020) Javed Akhtar et al.   BMC CANCER

Potential of Protein-based Anti-metastatic Therapy with Serpins and Inter α-Trypsin Inhibitors

(2018) ULRICH H. WEIDLE et al.   Cancer Genomics & Proteomics

Overexpression of the Kininogen-1 inhibits proliferation and induces apoptosis of glioma cells

(2018) Jinfang Xu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets

(2018) Damian Szklarczyk et al.   NUCLEIC ACIDS RESEARCH

Multi-Omics Data Integration and Mapping of Altered Kinases to Pathways Reveal Gonadotropin Hormone Signaling in Glioblastoma

(2016) Savita Jayaram et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

Microsomal membrane proteome of low grade diffuse astrocytomas: Differentially expressed proteins and candidate surveillance biomarkers

(2016) Ravindra Varma Polisetty et al.   Scientific Reports

Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone

(2015) Miklos Jaszberenyi et al.   Oncotarget

Silencing of the GnRH Type 1 Receptor Blocks the Antiproliferative Effect of the GnRH Agonist, Leuprolide, on the Androgen-Independent Prostate Cancer Cell Line DU145

(2013) YH Ko et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Heterogeneous Nuclear Ribonucleoproteins and Their Interactors Are a Major Class of Deregulated Proteins in Anaplastic Astrocytoma: A Grade III Malignant Glioma

(2013) Ravindra Varma Polisetty et al.   JOURNAL OF PROTEOME RESEARCH

Proteins with Altered Levels in Plasma from Glioblastoma Patients as Revealed by iTRAQ-Based Quantitative Proteomic Analysis

(2012) Poonam Gautam et al.   PLoS One

Glioma proteomics: Status and perspectives

(2010) Simone P. Niclou et al.   Journal of Proteomics

Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin

(2010) Siti S Abdullah-Soheimi et al.   Proteome Science

Gonadotropin-Releasing Hormone Type II Induces Apoptosis of Human Endometrial Cancer Cells by Activating GADD45 

(2009) H.-M. Wu et al.   CANCER RESEARCH

Type I Gonadotropin-Releasing Hormone Receptor Mediates the Antiproliferative Effects of GnRH-II on Prostate Cancer Cells

(2009) Marina Montagnani Marelli et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Epidermal Growth Factor-Induced GnRH-II Synthesis Contributes to Ovarian Cancer Cell Invasion

(2009) Song Ling Poon et al.   MOLECULAR ENDOCRINOLOGY

Cleaved high-molecular-weight kininogen and its domain 5 inhibit migration and invasion of human prostate cancer cells through the epidermal growth factor receptor pathway

(2009) Y Liu et al.   ONCOGENE

Human gonadotropin-releasing hormone receptor-activated cellular functions and signaling pathways in extra-pituitary tissues and cancer cells (Review)

(2009) Aguilar-Rojas   ONCOLOGY REPORTS

Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells

(2008) Stefanie Fister et al.   GYNECOLOGICAL ENDOCRINOLOGY